Skip to main content

Table 3 Main inborn errors of metabolism associated with thyroid dysfunction

From: Endocrine manifestations related to inherited metabolic diseases in adults

DISEASES

CLINICAL MANIFESTATIONS

ENDOCRINE DYSFUNCTION: DYSTHYRODISM

DIAGNOSIS

TREATMENT

Energy defect

    

Mitochondrial disease

Involving seemingly unrelated organs

Maternal inheritance

Deafness, retinitis pigmentosa

Short stature,

Neuromuscular symptoms

Kidney insufficiency

Goiter, hypo-/hyperthyroidism, thyrotropic insufficiency

Non-autoimmune diabetes in a lean patient > 30 years

More rarely hypoparathyroidism, adrenal insufficiency, hypogonadism, hypopituitarism

Blood lactate/pyruvate ratio (high)

Blood ßOH butyrate/acetoacetate ratio: high

CSF lactate (high)

Urinary organic acids

Plasma amino acids: high alanine & proline

Muscle biopsy

Mitochondrial DNA study

Discuss coenzyme Q10

Glycogenosis

Liver involvement

Infections in type Ib

Growth failure

Renal complications in adulthood

Increased prevalence of autoimmune hypothyroidism in type I b

Children: fasting ketotic hypoglycaemia

Adults:

I, III types: polycystic ovary syndrome, diabetes, osteoporosis

VI, IX types: spontaneous recovering delayed puberty

Fasting hypoglycaemia

Hyper-lipaemia, -uricaemia

Hyperlactataemia:

- fasting predominant: type I

- postprandial predominant: type III, VI, IX

Leukocytes DNA gene mutation

Frequent food intake

Uncooked cornstarch

Low carbohydrate glycaemic index

Night enteral feeding

G-CSF in Ib type, Allopurinol

Avoid oestroprogestative pills

Degradation and synthesis of complex molecules

    

Fabry disease

Acroparesthesia

Angiokeratoma

Stroke at young age

Renal, heart and eye involvement in boys

Subclinical hypothyroidism

Isolated case report of subclinical adrenal insufficiency and hypoparathyroidism

Infertility, osteoporosis

Alpha-galactosidase A in males

Leukocytes GLA gene mutation in females

(X-linked)

Substitutive recombinant

enzyme therapy

Cystinosis

3 forms: infantile, juvenile, ophthalmic (adulthood)

Liver and muscle involvement

Evolution to end stage renal disease

Hypothyroidism > 50%

Hypergonadotropic hypogonadism (in males)

Insulin-dependant diabetes

Growth failure

Gluco-phospho-aminic diabetes

Hypokalaemia, acidosis,

Leukocyte cystin measurement

Leukocytes CTNS gene mutation

Electrolyte supplementation

Vitamins

Indomethacin

Cysteamine

Type 1 hyperoxaluria

Recurrent oxalic lithiasis leading to end stage renal disease

Bone, eye, heart involvement

Hypothyroidism

- often severe

- sometimes signalling disease

Hyperoxaluria

Hyperglycoluria

Alanine-glyoxylate-aminotransferase measurement on liver biopsy

Leukocytes AGXT gene mutation

Abundant hydration

Urine alkalinisation

Pyridoxine phosphate

Kidney and liver transplantation

Neutral lipid storage disease

Ichtiosis or Chanarin-Dorfman syndrome

or myopathy/cardiomyopathy

Hepatomegaly

Central nervous system involvement

Nodular dystrophy of the thyroid

(clear cells follicular adenoma)

Normal lipid levels

CPK sometimes moderately increased

Accumulation of triglycerides

- in leukocytes (Jordan's abnormality)

- in muscle, skin fibroblasts, liver (steatosis)

Leukocytes or fibroblasts ABHD5 or PNPLA2 gene mutation

No effective treatment

MCT8 deficiency

Or Allan-Erndon-Dudley syndrome

Severe cognitive deficiency,

Hypotonia and dystonic movement

Progressive spastic quadriplegia in boys

High serum T 3 - low serum rT3

Low serum T4 (sometimes normal)

Normal serum TSH (or slightly elevated)

Nodular dystrophy of the thyroid

Leukocytes MCT8 gene mutation

(X-linked)

Propylthiouracil and L- thyroxin

Congenital disorders of glycosylation

Affect nearly all organs and systems

Often, significant neurological component.

Most of the time difficulties in TSH measurement

Always check with a reference method

Rare congenital hypothyroidism

Hypogonadism

N-glycosylation diseases:

serum transferrin isoelectrofocusing

O-glycosylation disorders:

apo CIII isoelectro-focusing,

leukocytes DNA molecular study

Inhibitors of phosphomannose isomerase under evaluation in CDG-Ia

Mannose in CDG-Ib

Selenoprotein deficiency disorder

Myopathy,

Dermal photosensitivity

Deficiency of deiodinases: low serum T3 and and high serum T4

Oligospermia

Leukocytes SECISBP2 gene mutation

 

Intoxication disorders

    

Haemochromatosis

Liver, rheumatologic and heart involvement

Hypo- and hyperthyroidism: ≤ 1%

Diabetes (10%)Peripheral hypogonadism (5-10%)

Adrenal insufficiency, hypopituitarism, and hypoparathyroidism: similar to the general population (except for secondary iron overload)

Transferrin saturation

Serum ferritin

Leukocytes HFE gene mutation

Phlebotomy

Iron chelation

  1. Abbreviations 3,3',5-triiodothyronine: T3; 3,3',5'-triiodothyronine: reverse T3 or rT3; tetraiodothyronine: thyroxine or T4; ATGL or Adipose triglyceride lipase, encoded by the gene PNPLA2 or patatin-like phospholipase domain containing 2; or alpha/beta-hydrolase domain-containing protein 5, encoded by ABHD5 gene (also called comparative gene identification-58); AGTX or Alanine-glyoxylate-aminotransferase gene; CDG or congenital disorders of glycosylation; CPK: creatin phospho kinase; CSF: cerebrospinal fluid; MCT8 (Monocarboxylate Transporter 8) deficiency or Allan-Erndon-Dudley syndrome or SLC16A2-Specific Thyroid Hormone Cell Transporter Deficiency; SECISBP2 or Sec insertion sequence-binding protein 2 (also known as SBP2)